Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-21-043000
Filing Date
2021-06-24
Accepted
2021-06-24 16:10:00
Documents
1
Period of Report
2021-06-23

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4045
  Complete submission text file 0001209191-21-043000.txt   5877
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Issuer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Reporting) CIK: 0001693011 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39397 | Film No.: 211042938
SIC: 2834 Pharmaceutical Preparations